IL6 and neoplasm: Further, LINC02268 could activate the interleukin-6 (IL6)/janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) signaling pathway, crucial for driving tumor advancement and metastasis in the tumor microenvironment (Wei et al., 2021; Johnson et al., 2018).